Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Capital Employed (2016 - 2021)

Historic Return on Capital Employed for Neurocrine Biosciences (NBIX) over the last 11 years, with Q3 2021 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Capital Employed fell 1000.0% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.12% for FY2019, which is 800.0% up from last year.
  • Neurocrine Biosciences' Return on Capital Employed amounted to 0.05% in Q3 2021, which was down 1000.0% from 0.07% recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Return on Capital Employed peaked at 0.32% during Q2 2020, and registered a low of 0.68% during Q1 2017.
  • Its 5-year average for Return on Capital Employed is 0.03%, with a median of 0.04% in 2018.
  • In the last 5 years, Neurocrine Biosciences' Return on Capital Employed plummeted by -4300bps in 2017 and then surged by 5600bps in 2018.
  • Neurocrine Biosciences' Return on Capital Employed (Quarter) stood at 0.18% in 2017, then skyrocketed by 124bps to 0.04% in 2018, then soared by 153bps to 0.11% in 2019, then soared by 46bps to 0.16% in 2020, then plummeted by -66bps to 0.05% in 2021.
  • Its last three reported values are 0.05% in Q3 2021, 0.07% for Q2 2021, and 0.08% during Q1 2021.